MoonLake Immunotherapeutics
MLTX
#5654
Rank
HK$10.02 B
Marketcap
HK$137.57
Share price
4.96%
Change (1 day)
-57.64%
Change (1 year)

Revenue for MoonLake Immunotherapeutics (MLTX)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MoonLake Immunotherapeutics from 2022 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A
2023 N/A
2022 N/A